Invesco Ltd. Xencor Inc Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Xencor Inc stock. As of the latest transaction made, Invesco Ltd. holds 610,875 shares of XNCR stock, worth $14.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

610,875

Previous 491,264 24.35%

Holding current value

$14.7 Million

Previous $9.3 Million 32.1%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$15.7 - $21.65 $1.88 Million - $2.59 Million	119,611 Added 24.35%	610,875 $12.3 Million
Q2 2024 Aug 13, 2024	BUY	$18.21 - $24.5 $5.25 Million - $7.06 Million	288,309 Added 142.06%	491,264 $9.3 Million
Q1 2024 May 14, 2024	SELL	$18.65 - $26.52 $456,850 - $649,633	-24,496 Reduced 10.77%	202,955 $4.49 Million
Q4 2023 Feb 12, 2024	SELL	$16.53 - $21.42 $5.43 Million - $7.03 Million	-328,358 Reduced 59.08%	227,451 $4.83 Million
Q3 2023 Nov 13, 2023	BUY	$20.08 - $25.39 $488,004 - $617,053	24,303 Added 4.57%	555,809 $11.2 Million
Q2 2023 Aug 11, 2023	BUY	$24.77 - $29.9 $475,608 - $574,109	19,201 Added 3.75%	531,506 $13.3 Million
Q1 2023 May 12, 2023	SELL	$25.95 - $36.95 $1.06 Million - $1.51 Million	-40,811 Reduced 7.38%	512,305 $14.3 Million
Q4 2022 Feb 13, 2023	BUY	$24.79 - $30.86 $982,477 - $1.22 Million	39,632 Added 7.72%	553,116 $14.4 Million
Q3 2022 Nov 14, 2022	SELL	$24.62 - $32.44 $875,241 - $1.15 Million	-35,550 Reduced 6.48%	513,484 $13.3 Million
Q2 2022 Aug 15, 2022	BUY	$19.74 - $29.01 $1.13 Million - $1.67 Million	57,496 Added 11.7%	549,034 $15 Million
Q1 2022 May 16, 2022	BUY	$26.68 - $41.63 $4.94 Million - $7.71 Million	185,290 Added 60.5%	491,538 $13.1 Million
Q4 2021 Feb 14, 2022	SELL	$33.67 - $43.44 $9.08 Million - $11.7 Million	-269,824 Reduced 46.84%	306,248 $12.3 Million
Q3 2021 Nov 15, 2021	BUY	$30.65 - $35.68 $1.24 Million - $1.44 Million	40,355 Added 7.53%	576,072 $18.8 Million
Q2 2021 Aug 17, 2021	BUY	$34.33 - $44.68 $1.22 Million - $1.58 Million	35,436 Added 7.08%	535,717 $18.5 Million
Q1 2021 May 17, 2021	BUY	$40.81 - $53.88 $406,100 - $536,159	9,951 Added 2.03%	500,281 $21.5 Million
Q4 2020 Feb 16, 2021	BUY	$36.63 - $47.63 $6.78 Million - $8.81 Million	185,002 Added 60.59%	490,330 $21.4 Million
Q3 2020 Nov 16, 2020	SELL	$30.09 - $43.02 $5.2 Million - $7.43 Million	-172,660 Reduced 36.12%	305,328 $11.8 Million
Q2 2020 Aug 14, 2020	BUY	$27.76 - $33.42 $755,210 - $909,191	27,205 Added 6.04%	477,988 $15.5 Million
Q1 2020 May 15, 2020	BUY	$20.69 - $37.79 $3.58 Million - $6.54 Million	173,009 Added 62.28%	450,783 $13.5 Million
Q4 2019 Feb 14, 2020	SELL	$32.75 - $41.43 $6.9 Million - $8.73 Million	-210,602 Reduced 43.12%	277,774 $9.55 Million
Q3 2019 Nov 14, 2019	BUY	$33.73 - $46.27 $16.2 Million - $22.2 Million	480,283 Added 5934.55%	488,376 $16.5 Million
Q2 2019 Aug 14, 2019	SELL	$29.6 - $40.93 $174,669 - $241,527	-5,901 Reduced 42.17%	8,093 $331,000
Q1 2019 May 15, 2019	SELL	$27.85 - $38.09 $142,452 - $194,830	-5,115 Reduced 26.77%	13,994 $435,000
Q4 2018 Feb 14, 2019	BUY	$32.39 - $42.05 $618,940 - $803,533	19,109 New	19,109 $691,000

Others Institutions Holding XNCR

# of Institutions

215

Shares Held

71.5M

Call Options Held

2.5K

Put Options Held

7.9K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.44B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account